X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES SHASUN PHARMA JUBILANT LIFE SCIENCES/
SHASUN PHARMA
 
P/E (TTM) x 19.2 123.9 15.5% View Chart
P/BV x 4.6 8.5 54.2% View Chart
Dividend Yield % 0.4 0.2 168.7%  

Financials

 JUBILANT LIFE SCIENCES   SHASUN PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
SHASUN PHARMA
Mar-14
JUBILANT LIFE SCIENCES/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs18794 198.3%   
Low Rs6546 142.8%   
Sales per share (Unadj.) Rs364.3214.2 170.1%  
Earnings per share (Unadj.) Rs6.85.3 128.3%  
Cash flow per share (Unadj.) Rs24.515.8 154.9%  
Dividends per share (Unadj.) Rs3.001.00 300.0%  
Dividend yield (eoy) %2.41.4 166.5%  
Book value per share (Unadj.) Rs164.953.3 309.1%  
Shares outstanding (eoy) m159.2856.62 281.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.3 105.9%   
Avg P/E ratio x18.413.1 140.4%  
P/CF ratio (eoy) x5.14.4 116.4%  
Price / Book Value ratio x0.81.3 58.3%  
Dividend payout %43.818.7 233.8%   
Avg Mkt Cap Rs m20,0613,958 506.9%   
No. of employees `0006.2NA-   
Total wages/salary Rs m11,0522,164 510.8%   
Avg. sales/employee Rs Th9,383.0NM-  
Avg. wages/employee Rs Th1,786.9NM-  
Avg. net profit/employee Rs Th176.3NM-  
INCOME DATA
Net Sales Rs m58,03412,127 478.6%  
Other income Rs m191229 83.1%   
Total revenues Rs m58,22412,356 471.2%   
Gross profit Rs m5,7861,009 573.4%  
Depreciation Rs m2,812594 473.7%   
Interest Rs m3,237415 779.9%   
Profit before tax Rs m-72230 -31.4%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m696-73 -957.6%   
Profit after tax Rs m1,090302 360.9%  
Gross profit margin %10.08.3 119.8%  
Effective tax rate %-965.9-31.7 3,050.9%   
Net profit margin %1.92.5 75.4%  
BALANCE SHEET DATA
Current assets Rs m29,2806,884 425.3%   
Current liabilities Rs m38,9128,456 460.2%   
Net working cap to sales %-16.6-13.0 128.1%  
Current ratio x0.80.8 92.4%  
Inventory Days Days8462 136.9%  
Debtors Days Days51108 47.1%  
Net fixed assets Rs m55,7124,970 1,120.9%   
Share capital Rs m155113 136.4%   
"Free" reserves Rs m20,9682,875 729.3%   
Net worth Rs m26,2653,020 869.6%   
Long term debt Rs m17,1691,817 944.7%   
Total assets Rs m88,60613,347 663.9%  
Interest coverage x1.01.6 62.9%   
Debt to equity ratio x0.70.6 108.6%  
Sales to assets ratio x0.70.9 72.1%   
Return on assets %4.95.4 90.9%  
Return on equity %4.210.0 41.5%  
Return on capital %11.613.3 86.8%  
Exports to sales %37.846.4 81.5%   
Imports to sales %16.514.2 115.7%   
Exports (fob) Rs m21,9335,622 390.2%   
Imports (cif) Rs m9,5671,728 553.8%   
Fx inflow Rs m22,0045,843 376.6%   
Fx outflow Rs m11,7492,173 540.6%   
Net fx Rs m10,2553,669 279.5%   
CASH FLOW
From Operations Rs m8,026398 2,018.6%  
From Investments Rs m-1,744-1,635 106.7%  
From Financial Activity Rs m-4,4471,309 -339.9%  
Net Cashflow Rs m1,83471 2,576.5%  

Share Holding

Indian Promoters % 45.6 39.2 116.3%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 3.6 241.7%  
FIIs % 21.2 17.6 120.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 39.6 53.3%  
Shareholders   23,815 20,750 114.8%  
Pledged promoter(s) holding % 15.9 12.3 129.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   ORCHID PHARMA LTD  CIPLA  TORRENT PHARMA  ALEMBIC LTD  WYETH LTD  

Compare JUBILANT LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Trade War Fears; Widening of Trade Deficit and Top Stocks in Action Today(Pre-Open)

Indian share markets trimmed their day's losses and ended flat on Friday amid weakness in their Asian peers, that wobbled on Friday as investors braced for US tariffs against China.

Related Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jun 15, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES - ALEMBIC PHARMA COMPARISON

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS